• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对卡西 Bhatla 等人的勘误。在晚期头颈癌中化疗的辐射价值有多少?(《国际放射肿瘤学、生物学、物理学杂志》2007 年;68:1491 - 1495)

Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer? (Int j radiat oncol biol phys 2007;68:1491-1495).

作者信息

Fowler Jack F

机构信息

Department of Human Oncology and Medical Physics, University of Wisconsin, Madison, WI, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):326-9. doi: 10.1016/j.ijrobp.2008.01.052.

DOI:10.1016/j.ijrobp.2008.01.052
PMID:18474309
Abstract

PURPOSE

To correct several elementary radiobiologic errors in the otherwise admirable article by Kasibhatla, Kirkpatrick, and Brizel (2007) on estimating the equivalent radiation effect of the concomitant chemotherapy in head-and-neck chemoradiotherapy.

METHODS AND MATERIALS

(1) Their equation was wrong because it omitted the lag or onset time of repopulation in tumors, Tk. Instead of zero days this should be 18-35 days. (2) Instead of a doubling time of 5 days, at most 3 days should be used for head-and-neck tumors. (3) Their slope "S" (the gamma-50 slope) for head-and-neck tumors should be 1.7, not 1.1. The same percentages of increased locoregional control as quoted by Kasibhatla et al. are used.

RESULTS

The average time-corrected biologically effective dose for the 16 schedules listed should be 72.4 instead of 63.1 Gy(10). The average gains in locoregional tumor control are the equivalent of 8.8 Gy(10), not 10.6 Gy(10) (p = 0.05).

CONCLUSIONS

The equivalent number of 2-Gy fractions of concomitant chemotherapy as used in the 16 listed schedules is 3.6 (95% confidence interval, 2.7-4.1), not 5 as claimed by Kasibhatla et al. The difference is statistically significant (p < 0.001).

摘要

目的

纠正卡西巴特拉、柯克帕特里克和布里泽尔(2007年)在关于估计头颈部放化疗中同步化疗等效辐射效应的那篇原本令人钦佩的文章中的几个基本放射生物学错误。

方法与材料

(1)他们的公式有误,因为它忽略了肿瘤再增殖的延迟或起始时间Tk。这个时间不应为零天,而应为18 - 35天。(2)对于头颈部肿瘤,不应使用5天的倍增时间,最多应使用3天。(3)他们对头颈部肿瘤的斜率“S”(γ - 50斜率)应为1.7,而非1.1。使用与卡西巴特拉等人所引用的相同的局部区域控制增加百分比。

结果

列出的16个治疗方案的平均时间校正生物等效剂量应为72.4,而非63.1 Gy(10)。局部区域肿瘤控制的平均增益相当于8.8 Gy(10),而非10.6 Gy(10)(p = 0.05)。

结论

列出的16个治疗方案中所使用的同步化疗2 - Gy分次等效数量为3.6(95%置信区间,2.7 - 4.1),而非卡西巴特拉等人所声称的5。差异具有统计学意义(p < 0.001)。

相似文献

1
Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer? (Int j radiat oncol biol phys 2007;68:1491-1495).对卡西 Bhatla 等人的勘误。在晚期头颈癌中化疗的辐射价值有多少?(《国际放射肿瘤学、生物学、物理学杂志》2007 年;68:1491 - 1495)
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):326-9. doi: 10.1016/j.ijrobp.2008.01.052.
2
How much radiation is the chemotherapy worth in advanced head and neck cancer?在晚期头颈癌中,化疗的辐射价值有多大?
Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1491-5. doi: 10.1016/j.ijrobp.2007.03.025.
3
Adjuvant neck dissection after concurrent chemoradiation for advanced head-and-neck cancer: in regard to Brizel et al. (Int J Radiat Oncol Biol Phys 2004;58: 1418-1423).
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1338. doi: 10.1016/j.ijrobp.2004.07.693.
4
Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions: in regard to Beuve et al. (Int J Radiat Oncol Biol Phys, In Press).
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):302-3; author reply 303. doi: 10.1016/j.ijrobp.2008.05.032.
5
In regards to Barkati et al. (Int J Radiat Oncol Biol Phys 2010;76:410-416).
Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):639-40. doi: 10.1016/j.ijrobp.2010.03.057. Epub 2010 Jun 11.
6
Re-irradiation for recurrent head and neck cancer: in regard to Lee et Al. (Int j radiat oncol biol phys 2007;68:731-740).复发性头颈癌的再照射:关于Lee等人(《国际放射肿瘤学、生物学、物理学杂志》2007年;68:731 - 740)。
Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1652-3; author reply 1653. doi: 10.1016/j.ijrobp.2007.08.013.
7
Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.放疗和顺铂化疗对头颈部癌患者感音神经性听力损失的相对影响
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):779-88. doi: 10.1016/j.ijrobp.2008.05.040. Epub 2008 Aug 15.
8
Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.同步化疗加超分割加速放疗对晚期头颈部鳞状细胞癌的影响。
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1088-95. doi: 10.1016/j.ijrobp.2008.05.042. Epub 2008 Aug 15.
9
Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer: in regard to Schoenfeld et al. (Int J Radiat Oncol Biol Phys 2008;71:377-385).
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1271-2; author reply 1272. doi: 10.1016/j.ijrobp.2008.07.022.
10
Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling.线性二次放射生物学模型中参数的敏感性分析
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1532-7. doi: 10.1016/j.ijrobp.2008.11.039.

引用本文的文献

1
Thyroid Dosimetry and Its Association With Radiation-Induced Hypothyroidism in Head and Neck Cancer Patients Treated With Conformal Radiotherapy: An Observational Study.甲状腺剂量测定及其与接受适形放疗的头颈癌患者放射性甲状腺功能减退的关联:一项观察性研究。
Cureus. 2025 Jan 29;17(1):e78220. doi: 10.7759/cureus.78220. eCollection 2025 Jan.
2
Accelerated Radiotherapy Alone Versus Chemoradiation in Locally Advanced Carcinoma Cervix: Long-Term Outcomes.局部晚期宫颈癌单纯加速放疗与放化疗的长期疗效比较
Cureus. 2024 Jul 22;16(7):e65154. doi: 10.7759/cureus.65154. eCollection 2024 Jul.
3
Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
在 COVID-19 大流行期间,头颈部癌症采用每分次 2.4 Gy 的低分割放射治疗:玛嘉烈公主医院的经验和建议。
Cancer. 2020 Aug 1;126(15):3426-3437. doi: 10.1002/cncr.32968. Epub 2020 Jun 1.
4
Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients.整体同期放化疗持续时间对 IIIB/C 期非小细胞肺癌患者生存结局的意义:956 例患者分析。
PLoS One. 2019 Jul 22;14(7):e0218627. doi: 10.1371/journal.pone.0218627. eCollection 2019.
5
Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.局部晚期头颈部鳞状细胞癌选择性淋巴结剂量减少的单臂 2 期试验。
Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1210-1216. doi: 10.1016/j.ijrobp.2017.12.277. Epub 2017 Dec 28.
6
Unresectable squamous cell carcinoma of upper trachea with long-term survival after concurrent chemoradiotherapy.不可切除的上气管鳞状细胞癌经同步放化疗后长期存活
BMJ Case Rep. 2017 Aug 11;2017:bcr-2017-221284. doi: 10.1136/bcr-2017-221284.
7
Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.选择性放射剂量递增和肿瘤缺氧状态对头颈部肿瘤放化疗后局部区域肿瘤控制有影响吗?ESCALOX方案。
Radiat Oncol. 2017 Mar 1;12(1):45. doi: 10.1186/s13014-017-0776-1.
8
An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result.调强放疗治疗鼻咽癌时,46 Gy的选择性放射剂量是可行的:长期随访结果。
Medicine (Baltimore). 2017 Feb;96(6):e6036. doi: 10.1097/MD.0000000000006036.
9
Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy.在联合治疗中使用高剂量分割放射疗法的挑战。
Front Oncol. 2016 Jun 30;6:165. doi: 10.3389/fonc.2016.00165. eCollection 2016.
10
Accelerated hypofractionated radiotherapy with concomitant chemotherapy in locally advanced squamous cell carcinoma of lung: evaluation of response, survival, toxicity and quality of life from a Phase II randomized study.局部晚期肺鳞状细胞癌同步放化疗的加速超分割放疗:一项II期随机研究的疗效、生存、毒性及生活质量评估
Br J Radiol. 2016 Jun;89(1062):20150966. doi: 10.1259/bjr.20150966. Epub 2016 Mar 17.